Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Post by TitanTraderon Jun 28, 2019 9:35am
116 Views
Post# 29873441

First quarter financials

First quarter financialsTmx Mobile QUOTE: GO LOOKUP RECENT NEWS Invictus MD Strategies Corp (GENE - TSXV) INVICTUS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS Vancouver, British Columbia, June 28, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, June 28, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) today reported financial results for the first quarter ended April 30, 2019. We are pleased with the progress on reducing the cost of Invictus operations and the increases to date on the income generation capacity of the Company. Continued focus on increasing capacity and cost reduction is paramount in developing a profitable business, stated Mr. Trevor Dixon, Chief Executive Officer of Invictus. Summary Financial Results Revenue was $1.6 million in the first quarter, an increase of 35% from the prior quarter ($1.2 million) and an increase of 23% from the prior year quarter ($1.3 million). Increase in revenue from the prior quarter was primarily due to the Company commencing sales to Ontario in March 2019. Gross margin was $1.2 million (77%) in the first quarter, as compared to $0.6 million (44%) in the prior year quarter. Increase in gross margin was primarily due to fair value adjustments related to our biological assets. Sales and marketing (S&M) expense was $1.3 million in the first quarter, a decrease of 74% from the prior quarter ($4.9 million) and an increase of 31% from the prior year quarter ($1.0 million). Decrease in S&M expense from the prior quarter is due to cost reduction initiatives implemented during the period. General and administrative (G&A) expense was $2.7 million in the first quarter, consistent with the prior quarter ($2.7 million) and an increase of 51% from the prior year quarter ($1.8 million). Increase in G&A expense from the prior year quarter is primarily due to the ramp-up of operations as a result of the build-out of our cannabis cultivation facilities. Net loss was $4.6 million in the first quarter, a decrease of 68% from the prior quarter ($14.3 million) and an increase of 53% from the prior year quarter ($3.0 million). The Companys unaudited condensed interim consolidated financial statements and managements discussion and analysis of the results of operations and financial condition of Invictus for the three months ended April 30, 2019, are available under the Companys profile on SEDAR at www.SEDAR.com. On Behalf of the Board Trevor Dixon Chief Executive Officer Investor Relations 1-844-800-6086 E-Mail: connect@invictus-md.com
<< Previous
Bullboard Posts
Next >>